China Vanke Bilan de santé

Santé financière contrôle des critères 3/6

China Vanke possède un total de capitaux propres de CN¥374.4B et une dette totale de CN¥329.2B, ce qui porte son ratio d'endettement à 87.9%. Son actif total et son passif total sont CN¥1,357.2B et de CN¥982.8B.

Informations clés

87.9%

Ratio d'endettement

CN¥329.17b

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	CN¥77.33b
Fonds propres	CN¥374.36b
Total du passif	CN¥982.84b
Total des actifs	CN¥1.36t

Mises à jour récentes de la santé financière

Is China Vanke (SZSE:000002) Using Too Much Debt?

Sep 30

China Vanke (SZSE:000002) Has No Shortage Of Debt

May 28

Recent updates

China Vanke Co., Ltd. (SZSE:000002) Surges 44% Yet Its Low P/S Is No Reason For Excitement

Oct 01

Is China Vanke (SZSE:000002) Using Too Much Debt?

Sep 30

The Market Doesn't Like What It Sees From China Vanke Co., Ltd.'s (SZSE:000002) Earnings Yet

Aug 16

China Vanke (SZSE:000002) Has No Shortage Of Debt

May 28

China Vanke Co., Ltd. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

May 01

Why Investors Shouldn't Be Surprised By China Vanke Co., Ltd.'s (SZSE:000002) 25% Share Price Plunge

Apr 16

Time To Worry? Analysts Are Downgrading Their China Vanke Co., Ltd. (SZSE:000002) Outlook

Apr 09

Earnings Miss: China Vanke Co., Ltd. Missed EPS By 36% And Analysts Are Revising Their Forecasts

Mar 31

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 000002 ( CN¥1,016.3B ) dépassent ses passifs à court terme ( CN¥750.8B ).

Passif à long terme: Les actifs à court terme de 000002 ( CN¥1,016.3B ) dépassent ses passifs à long terme ( CN¥232.0B ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de 000002 ( 67.3% ) est considéré comme élevé.

Réduire la dette: Le ratio d'endettement de 000002 a été réduit de 94.2% à 87.9% au cours des 5 dernières années.

Couverture de la dette: Le flux de trésorerie opérationnel de 000002 est négatif, par conséquent la dette n'est pas bien couverte.

Couverture des intérêts: Données insuffisantes pour déterminer si les paiements d'intérêts de 000002 sur sa dette sont bien couverts par l'EBIT.

China Vanke Bilan de santé

Santé financière contrôle des critères 3/6

Informations clés

Mises à jour récentes de la santé financière

Is China Vanke (SZSE:000002) Using Too Much Debt?

China Vanke (SZSE:000002) Has No Shortage Of Debt

Recent updates

Third quarter 2024 earnings released: CN¥0.68 loss per share (vs CN¥0.32 profit in 3Q 2023)

Price target increased by 7.4% to CN¥7.26

Price target increased by 7.2% to CN¥7.25

China Vanke Co., Ltd. (SZSE:000002) Surges 44% Yet Its Low P/S Is No Reason For Excitement

New minor risk - Share price stability

China Vanke Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Is China Vanke (SZSE:000002) Using Too Much Debt?

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

The Market Doesn't Like What It Sees From China Vanke Co., Ltd.'s (SZSE:000002) Earnings Yet

New major risk - Revenue and earnings growth

China Vanke Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

China Vanke (SZSE:000002) Has No Shortage Of Debt

Investor sentiment improves as stock rises 19%

Consensus EPS estimates fall by 12%

Price target decreased by 8.1% to CN¥8.28

China Vanke Co., Ltd. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

China Vanke Reportedly Seeks to Sell 21% Stake in GLP

Why Investors Shouldn't Be Surprised By China Vanke Co., Ltd.'s (SZSE:000002) 25% Share Price Plunge

Time To Worry? Analysts Are Downgrading Their China Vanke Co., Ltd. (SZSE:000002) Outlook

China Vanke Co., Ltd., Annual General Meeting, Apr 30, 2024

Consensus revenue estimates fall by 12%

Price target decreased by 15% to CN¥10.35

Earnings Miss: China Vanke Co., Ltd. Missed EPS By 36% And Analysts Are Revising Their Forecasts

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

China Vanke Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024

China Vanke Co., Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024

Price target decreased by 7.4% to CN¥14.43

Price target decreased by 7.0% to CN¥14.50

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

China Vanke Co., Ltd. Appoints Mr. Xin Jie as Deputy Chairman of the Board

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

China Vanke Co., Ltd. Announces Implementation of Cash Dividend for 2022, Payable on 25 August 2023

China Vanke Co., Ltd. Approves the Cash Dividend for the Year 2022

China Vanke Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 25 August 2023

China Vanke Co., Ltd. Announces Board and Committee Changes

China Vanke Co., Ltd., Annual General Meeting, Jun 30, 2023

Consensus EPS estimates fall by 13%

Price target decreased by 8.9% to CN¥19.69

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment improved over the past week

Less than half of directors are independent

Price target decreased to CN¥20.55

China Vanke Co., Ltd. to Report Q3, 2022 Results on Oct 28, 2022

President recently bought CN¥3.5m worth of stock

Executive Director recently bought CN¥350k worth of stock

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

China Vanke Co., Ltd. Announces Cash Dividend of A Shares for the Year 2021, Payment Date Is 25 August 2022

China Vanke Co., Ltd. to Report First Half, 2022 Results on Aug 30, 2022

Executive Director recently bought CN¥1.2m worth of stock

China Vanke Co., Ltd. Announces Final Dividend for the Year Ended 31 December 2021, Payable on August 25, 2022

China Vanke Co., Ltd. Announces Final Dividend for the Year Ended 31 December 2021, Payable on August 25, 2022

China Vanke Co., Ltd. Announced Dividend on Share H for 2021

Chairman of the Board & Group Partner recently bought CN¥1.6m worth of stock

China Vanke Co., Ltd., Annual General Meeting, Jun 28, 2022

China Vanke Co., Ltd. Announces Final Dividend for the Year Ended December 31, 2021, Payable on August 25, 2022

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Less than half of directors are independent

China Vanke Co., Ltd. to Report Q1, 2022 Results on Apr 28, 2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

China Vanke Co., Ltd. (SZSE:000002) announces an Equity Buyback for CNY 2,500 million worth of its shares.

Consensus forecasts updated

China Vanke Co., Ltd. Proposes Ordinary Final Dividend for the year ended December 31, 2021, Payable on 31 August 2022

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS CN¥0.48 (vs CN¥0.63 in 3Q 2020)

Second quarter 2021 earnings released

Price target decreased to CN¥29.19

Investor sentiment deteriorated over the past week

China Vanke Co., Ltd. (SZSE:000002) acquired Chengdu Shengshi Jingwei Real Estate Co Ltd from Chengdu Hillwest Development Co. Ltd. for approximately CNY 1.6 billion.

First quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.11 in 1Q 2020)

Non-Executive Director has left the company

Full year 2020 earnings released

New 90-day high: CN¥32.99